Inozyme Pharma Inc. (INZY): Price and Financial Metrics
INZY Price/Volume Stats
| Current price | $3.96 | 52-week high | $6.24 |
| Prev. close | $3.96 | 52-week low | $0.72 |
| Day low | $3.95 | Volume | 1,160,000 |
| Day high | $3.96 | Avg. volume | 1,501,187 |
| 50-day MA | $1.39 | Dividend yield | N/A |
| 200-day MA | $2.91 | Market Cap | 255.67M |
INZY Stock Price Chart Interactive Chart >
Inozyme Pharma Inc. (INZY) Company Bio
Inozyme Pharma engages in the research and development of pharmaceutical products. It specializes in developing new medicines for the treatment of abnormal mineralization and ABCC6 deficiency. The company was founded by Axel Bolte, Joseph P. Schlessinger and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
INZY Price Returns
| 1-mo | 312.50% |
| 3-mo | 216.80% |
| 6-mo | 50.00% |
| 1-year | -13.35% |
| 3-year | -1.00% |
| 5-year | N/A |
| YTD | 42.96% |
| 2024 | -34.98% |
| 2023 | 305.71% |
| 2022 | -84.60% |
| 2021 | -66.96% |
| 2020 | N/A |
Loading social stream, please wait...